InstaRX review

Define the clinical purpose before comparing the catalogue

The current homepage lists compounded semaglutide, compounded tirzepatide and NAD+ injections. These serve different proposed purposes and need separate clinical decisions. Availability on one platform does not establish that combining them is appropriate or that they form a complete preventive-health programme. ^[1]

The NAD+ safety notice acknowledges uncertainty about long-term effects. Its anti-aging presentation does not demonstrate longer healthy life. The weight outcome disclosure refers to customer-reported measurements, not a controlled assessment of an individual’s likely result. I would define the outcome and appropriate monitoring before considering a purchase. ^{[1] [2]}

Keep proposed markers separate from health outcomes with the biological-age testing evidence.

Ask which preparation and monitoring are actually provided

For NAD+, the reviewed pages do not establish a full concentration, volume, ingredient list or recurring quantity. The GLP-1 products are explicitly compounded and not FDA-approved; if the selected NAD+ preparation is compounded, the same approval limitation applies. General pharmacy-regulation claims do not verify the actual dispenser or batch. ^{[1] [2] [6]}

The consent allows clinical review, messages, audio/video and third-party testing where ordered. It does not establish a complete included laboratory panel, recurring preventive examination or fixed nutrition-appointment schedule. Ask what is clinically indicated for the particular service, who reviews it and what costs extra. ^{[3] [4]}

Compare another catalogue with separate treatment plans in our Fresh Day service-scope review.

Separate the consultation component from a complete service price

The terms say the $45 doctor consultation fee is included in the monthly price. This does not establish the full cost of either a NAD+ plan or a weight prescription, and it should not be added again as a separate surcharge. Obtain product-specific supply, laboratory, support and delivery costs in the selected quote. ^[3]

Subscription services renew at the then-current rate unless cancelled before renewal. Confirm the actual accepted date and cancellation method for each service. The reviewed terms do not establish a complete medical-nonapproval refund schedule or a specific order-preparation cutoff; no broad guarantee should be transferred from one product to another. ^{[3] [5]}

Separate each service and its testing costs in the health-service cost planner.

Compare another recurring purchase and cancellation arrangement in our NP2GO purchase-terms review.

Judge a defined care relationship rather than access alone

InstaRX identifies itself as a technology platform connecting independent clinicians and pharmacies. The terms name provider groups, but those names do not independently verify which professional will treat a patient or whether every service is available in that state. Confirm the actual assignment and eligibility before enrollment. ^[3]

Free shipping and quick-arrival marketing do not settle the prescription’s preparation time, delivery commitment or remedy for a damaged parcel. Obtain the accepted shipment and refund terms alongside the monitoring plan. I would compare a clearly described service here, without treating convenience, customer reports or a safety-page listing as proof of healthspan benefit. ^{[1] [4] [5]}

Compare purpose, follow-up and commitments in the health-service comparison.

Understanding the cost

No complete current NAD+ or GLP-1 plan total established from reviewed public pages. Terms include a $45 doctor consultation component in the monthly price; confirm each service’s full bill separately. No combined preventive-care package price or universal included test panel is established.